← Back to Janssen Pharmaceuticals Inc.
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19658174 | Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses | DUFFY, BRADLEY | 1643 | Other | Non-Final OA | — | Pending | Apr 24, 2026 |
| 19418900 | METHODS OF TREATING HIGH RISK MULTIPLE MYELOMA | SANG, HONG | 1646 | §102§103§112 | Final Rejection | — | Pending | Dec 12, 2025 |
| 19281154 | METHODS AND COMPOSITIONS FOR MONITORING THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA | IVICH, FERNANDO NMN | 1678 | §101§102§103§112Other | Non-Final OA | — | Pending | Jul 25, 2025 |
| 19107952 | PATIENT TRAINER MIRROR | OGLES, MATTHEW ERIC | 3791 | §101§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18939761 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING AMINOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE THEREOF | ROSENTHAL, ANDREW S | 1613 | §103DP | Non-Final OA | — | Pending | Nov 07, 2024 |
| 18846889 | SHELL FOR SMALL VIAL TO FIT INTO INJECTOR OR CAP REMOVER | WHITROCK, ZACHARIAH KIRBY | 3783 | §102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18771839 | Combination Therapies with Anti-CD38 Antibodies | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103DP | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18765663 | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody | PETRASH, HILARY ANN | 1644 | §102§112DP | Final Rejection | — | Pending | Jul 08, 2024 |
| 18721021 | Urinary Placement Catheter for Intravesical Devices | MENDEZ, MANUEL A | 3783 | §103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18711131 | Method of Treating Geographic Atrophy with a Gene Therapy Vector Expressing Soluble CD59 | POPA, ILEANA | 1633 | §102§103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18703264 | BIOSYNTHETIC MONOVALENT BINDING MOLECULES WITH ENHANCED EFFECTOR FUNCTIONS | HOLTZMAN, KATHERINE ANN | 1646 | §103§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18639233 | METHODS FOR TREATING MULTIPLE MYELOMA | FAUST, AMBER KATHLEEN | 1643 | §102§103DP | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18639242 | METHODS FOR TREATING MULTIPLE MYELOMA | EDGINGTONGIORDANO, FRANCESCA | 1643 | §103DP | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18613945 | USE OF APPROVED BISPECIFIC EGFR AND MET SPECIFIC ANTIBODY DRUG PRODUCT TO TREAT NON-SMALL CELL LUNG CANCER | LANDSMAN, ROBERT S | 1647 | §103 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18691254 | CD33 x Vd2 MULTISPECIFIC ANTIBODIES FOR THE TREATMENT OF CANCER | WEIDNER, ADAM M | 1675 | §112DP | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18592234 | BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA | MELCHIOR, JAMES RYLAND | 1644 | §101§102§103§112DP | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18588224 | COMPOSITIONS COMPRISING A BISPECIFIC GPRC5D/CD3 ANTIBODY | JOHNSON, TIRONE DEREK | 1675 | §101§103 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18583364 | Neoantigens Expressed In Ovarian Cancer And Their Uses | POPA, ILEANA | 1633 | §103 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18444595 | Anti-IL-23 Antibodies | SKELDING, ZACHARY S | 1644 | §112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18439951 | METHODS FOR TREATING MULTIPLE MYELOMA | BUNNER, BRIDGET E | 1647 | DP | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18545113 | ONCOLYTIC VIRUS AND USES THEREOF | MARVICH, MARIA | 1634 | §112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18528157 | ANTI- GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF | NATARAJAN, MEERA | 1643 | §112DP | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18558859 | UNIVERSAL RETARGETING OF ONCOLYTIC HSV | GRABER, JAMES J | 1631 | §103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18499720 | BCMA-TARGETED CAR-T CELL THERAPY OF MULTIPLE MYELOMA | HUYNH, PHUONG N | 1641 | §102§103§112DP | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18555924 | MOLECULES WITH ENGINEERED ANTIBODY CONSTANT REGION VARIANTS | HUYNH, PHUONG N | 1641 | §102§103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18552504 | ANTI-TAU ANTIBODIES AND USES THEREOF | XIAO, YAN | 1642 | DP | Non-Final OA | 28d | Pending | Sep 26, 2023 |
| 18549795 | BIOENGINEERED IMMUNOMODULATORY FUSION PROTEIN COMPOSITIONS | KAUFMAN, CLAIRE M | 1674 | §102§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18344973 | MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS | CANDELARIA, JULIANA IRENE | 1634 | §103 | Final Rejection | 21d | Pending | Jun 30, 2023 |
| 18216026 | Use of Anti-EGFR/Anti-Met Antibody to Treat Gastric or Esophageal Cancer | SULLIVAN, DENNIS JOHN | 1642 | §103Other | Non-Final OA | 54d | Pending | Jun 29, 2023 |
| 18210885 | Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody | BRISTOL, LYNN ANNE | 1643 | §103Other | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18327577 | METHOD OF TREATING INFLAMMATORY BOWEL DISEASE WITH A COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF ALPHA | SAOUD, CHRISTINE J | 1645 | DP | Final Rejection | 46d | Pending | Jun 01, 2023 |
| 18199007 | Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody | LOCKARD, JON MCCLELLAND | 1647 | §112 | Final Rejection | 6d | Pending | May 18, 2023 |
| 18249807 | PROTEINS COMPRISING DELTA-LIKE LIGAND 3 (DLL3) ANTIGEN BINDING DOMAINS AND THEIR USES | LI, RUIXIANG | 1674 | §112 | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18300288 | Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone | SULLIVAN, DENNIS JOHN | 1642 | §103DP | Non-Final OA | — | Pending | Apr 13, 2023 |
| 18300183 | Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | 70d overdue | Pending | Apr 13, 2023 |
| 18180693 | Palm Activated Drug Delivery Device | SCHMIDT, EMILY LOUISE | 3783 | DP | Non-Final OA | — | Pending | Mar 08, 2023 |
| 18175345 | Methods of Treating High Risk Multiple Myeloma | SANG, HONG | 1646 | DP | Final Rejection | 10d overdue | Pending | Feb 27, 2023 |
| 18166878 | Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody | FORD, VANESSA L | 1674 | §102§103 | Final Rejection | 17d overdue | Pending | Feb 09, 2023 |
| 18106531 | Methods for Reducing Infusion-Related Reactions in Patients Treated with EGFR/Met Bispecific Antibodies | REDDIG, PETER J | 1646 | §103DP | Final Rejection | 28d | Pending | Feb 07, 2023 |
| 18080639 | VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES | BARRERA, IMMACULADA | 1671 | DP | Final Rejection | 74d overdue | Pending | Dec 13, 2022 |
| 18009135 | CONTROLLED RELEASE OF SELF-EMBEDDING PARTICLES FOR LOCALIZED DRUG DELIVERY | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | — | Pending | Dec 08, 2022 |
| 18053904 | STABLE FORMULATIONS COMPRISING A BISPECIFIC BCMA/CD3 ANTIBODY | DUNN, LINDSAY MICHELLE | 1600 | §102§103 | Non-Final OA | — | Pending | Nov 09, 2022 |
| 18052172 | METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF GPRC5DXCD3 BISPECIFIC ANTIBODIES | GUSTILO, ESTELLA M | 1646 | §103§112Other | Final Rejection | 88d overdue | Pending | Nov 02, 2022 |
| 17918140 | SYSTEMS, MATERIALS, AND METHODS FOR REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC) IDENTIFICATION OF MULTI-SPECIFIC MOLECULES | BERKELEY, EMILY R | 1796 | §101§103 | Final Rejection | 20d | Pending | Oct 11, 2022 |
| 17860244 | Manufacturing Methods for Producing Anti-TNF Antibody Compositions | CUNNINGCHEN, KATHLEEN MARY | 1646 | §103§112 | Non-Final OA | — | Pending | Jul 08, 2022 |
| 17825244 | ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD79B ANTIBODIES | GUSTILO, ESTELLA M | 1646 | §103§112Other | Non-Final OA | 147d overdue | Pending | May 26, 2022 |
| 17752892 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROSTATE CANCER | SKOKO III, JOHN JOSEPH | 1643 | §103§112DP | Non-Final OA | 49d overdue | Pending | May 25, 2022 |
| 17767263 | MATERIALS AND METHODS FOR MASS SPECTROMETRIC PROTEIN ANALYSIS | SIMMONS, VALERIE MICHELLE | 1758 | §103 | Non-Final OA | 9d | Pending | Apr 07, 2022 |
| 17615949 | ANTI-TNF ANTIBODY COMPOSITIONS, AND METHODS FOR THE TREATMENT OF PSORIATIC ARTHRITIS | DAHLE, CHUN WU | 1641 | DP | Final Rejection | — | Pending | Dec 02, 2021 |
| 17240609 | Materials and Methods for Treating Juvenile Idiopathic Arthritis | HOLTZMAN, KATHERINE ANN | 1646 | §103Other | Non-Final OA | 13d | Pending | Apr 26, 2021 |
| 17235974 | NEUROLOGIC TOXICITY ASSESSMENT METHODS AND SYSTEMS FOR DOCUMENTING CHANGES IN HANDWRITING | ROBERTS, ANNA L | 3791 | §101§102 | Final Rejection | 164d overdue | Pending | Apr 21, 2021 |
| 17182429 | CAPACITY OPTIMIZATION ACROSS DISTRIBUTED MANUFACTURING SYSTEMS | LEE, PO HAN | 3623 | §101 | Final Rejection | 34d | Pending | Feb 23, 2021 |
| 16983212 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | VOKES, KATHLEEN PAIGE | 3783 | §103§112 | Non-Final OA | — | Pending | Aug 03, 2020 |
| 16797301 | Methods of Treating Newly Diagnosed Multiple Myeloma with a Combination of An Antibody that Specifically Binds CD38, Lenalidomide and Dexamethasone | SANG, HONG | 1646 | Other | Non-Final OA | 4d overdue | Pending | Feb 21, 2020 |
| 19029331 | MDR E. COLI IMMUNOGEN | GANGLE, BRIAN J | 1645 | §101§112DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 19023669 | COMPOSITIONS COMPRISING ATICAPRANT | YOUNG, MICAH PAUL | 1618 | §103DP | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18841723 | SMART LIQUID DRUG ADMINISTRATION | WILLIAMS, CATHERINE SERKE | 3993 | §102§103 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18727772 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION | RICCI, CRAIG D | 1611 | §103§112Other | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18498448 | COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION | GROOMS, TIFFANY NICOLE | 1637 | §103DP | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18317498 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | OUSPENSKI, ILIA I | 1644 | §112DP | Non-Final OA | — | Pending | May 15, 2023 |
| 17998592 | STABILIZED CORONAVIRUS SPIKE PROTEIN FUSION PROTEINS | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 170d overdue | Pending | Nov 11, 2022 |
| 17806581 | RECOMBINANT VIRUS REPLICON SYSTEMS AND USES THEREOF | MARVICH, MARIA | 1634 | §112Other | Non-Final OA | 43d overdue | Pending | Jun 13, 2022 |
| 18858037 | FREEZE DRIED COMPOSITIONS | LANKFORD JR, LEON B | 1657 | §103 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18705114 | IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | AGGARWAL, SAHIL CHANDER | — | §112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18408900 | METHODS OF TREATING HIV | SHIAO, REI TSANG | 1691 | DP | Final Rejection | — | Pending | Jan 10, 2024 |
| 18550323 | ANTIBACTERIAL COMPOUNDS | FERGUSON, JALISA HOLMES | 1626 | §112DP | Non-Final OA | — | Pending | Sep 13, 2023 |
| 18037204 | TREATMENT OR PREVENTION OF HIV INFECTION | SWIFT, CANDICE LEE | 1657 | §103§112Other | Final Rejection | 26d | Pending | May 16, 2023 |
| 17621759 | METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINE | RAMACHANDRAN, UMAMAHESWARI | 1627 | §103Other | Non-Final OA | — | Pending | Dec 22, 2021 |
| 17596538 | Recombinant Interleukin 12 Construct and Uses Thereof | GURLEY, JAMI MICHELLE | 1647 | §103 | Non-Final OA | 21d | Pending | Dec 13, 2021 |
